Thyrocare Technologies Limited
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical an… Read more
Thyrocare Technologies Limited (THYROCARE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.238x
Based on the latest financial reports, Thyrocare Technologies Limited (THYROCARE) has a cash flow conversion efficiency ratio of 0.238x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹1.27 Billion) by net assets (₹5.34 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Thyrocare Technologies Limited - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Thyrocare Technologies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Thyrocare Technologies Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Thyrocare Technologies Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gorilla Technology Group Inc.
NASDAQ:GRRR
|
-0.013x |
|
Heren Health Co Ltd
SHE:300550
|
0.007x |
|
SMS Electric Co Ltd Zhengzhou
SHE:002857
|
-0.033x |
|
First Copper Technology Co Ltd
TW:2009
|
0.033x |
|
Yindu Kitchen Equipment Co Ltd
SHG:603277
|
0.076x |
|
VT Industrial Technology Co Ltd
SHE:300707
|
0.049x |
|
Cytodyn Inc
OTCQB:CYDY
|
0.036x |
|
Community Health Systems Inc
NYSE:CYH
|
-0.073x |
Annual Cash Flow Conversion Efficiency for Thyrocare Technologies Limited (2011–2025)
The table below shows the annual cash flow conversion efficiency of Thyrocare Technologies Limited from 2011 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹5.47 Billion | ₹1.91 Billion | 0.350x | +10.08% |
| 2024-03-31 | ₹5.28 Billion | ₹1.68 Billion | 0.318x | +31.50% |
| 2023-03-31 | ₹5.35 Billion | ₹1.29 Billion | 0.242x | +12.18% |
| 2022-03-31 | ₹5.27 Billion | ₹1.13 Billion | 0.215x | -20.69% |
| 2021-03-31 | ₹4.27 Billion | ₹1.16 Billion | 0.272x | -40.60% |
| 2020-03-31 | ₹3.67 Billion | ₹1.68 Billion | 0.457x | +98.31% |
| 2019-03-31 | ₹4.35 Billion | ₹1.00 Billion | 0.231x | -4.52% |
| 2018-03-31 | ₹4.43 Billion | ₹1.07 Billion | 0.241x | +9.81% |
| 2017-03-31 | ₹4.07 Billion | ₹894.44 Million | 0.220x | +18.57% |
| 2016-03-31 | ₹3.66 Billion | ₹678.01 Million | 0.185x | +67.15% |
| 2015-03-31 | ₹3.11 Billion | ₹344.68 Million | 0.111x | -50.51% |
| 2014-03-31 | ₹2.06 Billion | ₹462.39 Million | 0.224x | -21.84% |
| 2013-03-31 | ₹1.60 Billion | ₹459.23 Million | 0.287x | -28.11% |
| 2012-03-31 | ₹1.02 Billion | ₹408.87 Million | 0.399x | -16.85% |
| 2011-03-31 | ₹675.33 Million | ₹324.07 Million | 0.480x | -- |